Skip to main content

Cencora Inc. Value Stock - Dividend - Research Selection

Amerisourcebergen

ISIN: US03073E1055 , WKN: 766149

Market price date:
Market price:  


Fundamental data and company key figures of the share

Annual reports in
Key figures
Cash flow
Net operating cash flow
Capital Expenditures
Free cash flow
Balance sheet
Total Equity
Liabilities & Shareholders equity
Income statement
Net income
Eps (diluted)
Diluted shares outstanding
Net sales/revenue

Fundamental ratios calculated on:

Ratios
Key figures
Cash flow
P/C
 
P/FC
Balance sheet
ROI
ROE
Income statement
P/E
Div. Yield %
P/B
P/S


Do you want to do make a detailed fundamental analysis of this stock?

✓ NEW Fundamental API Access to 500 data points per month
Fundamental data up to 25 years
Comparison to all other stocks by the FScore
Time saving!

How our site works ...

Non-binding 7 days without automatic subscription
 No termination required after the free week
Finanzoo fundamental analysis
Data updated daily
Virtual depots
Share alarms via email
Subscription can be canceled at any time at the end of the month 
Choice of desired shares
Over 2000 stock analyzes available
Bitcoin payment possible if you do not want to subscribe

Price for monthly subscription $ 19.99 / month including VAT.



Description Data
Symbol
Market Capitalization USD
Country
Indices
Sectors
Raw Data Source
Stock Split
Internet


Description of the company

AmerisourceBergen Corporation sources and distributes pharmaceutical products in the United States and internationally. Its Pharmaceutical Distribution segment distributes brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, outsourced compounded sterile preparations, and related services to various healthcare providers, including acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and other alternate site pharmacies, and other customers. It also provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; and packaging solutions to various institutional and retail healthcare providers. In addition, this segment provides pharmaceutical distribution and other services primarily to physicians who specialize in various disease states, primarily oncology, as well as to other healthcare providers, including hospitals and dialysis clinics; distributes plasma and other blood products, injectable pharmaceuticals, vaccines, and other specialty products; and offers third party logistics and outcomes research, and other services for biotechnology and other pharmaceutical manufacturers. The company\'s Other segment provides commercialization support services, including reimbursement support programs, outcomes research, contract field staffing, patient assistance and co-pay assistance programs, adherence programs, risk mitigation services, and other market access programs to pharmaceutical and biotechnology manufacturers; specialty transportation and logistics services for the biopharmaceutical industry; and animal health care products. It markets its products and services through independent sales forces and marketing organizations. AmerisourceBergen Corporation was founded in 1985 and is headquartered in Chesterbrook, Pennsylvania.

The Finanzoo GmbH assumes no liability for the accuracy of the information! All information is provided without warranty. Sources:: www.bundesanzeiger.de, www.sec.gov,


NEWS


Is Cencora (COR) Undervalued? Exploring the Quiet Rally and What It Means for Investors

2025-09-27
Cencora (COR) has caught the attention of investors this week, but not because of a single seismic event. Sometimes, the absence of headline-grabbing news is its own story, especially for a company with Cencora’s track record. When the stock quietly moves without a dramatic catalyst, it raises interesting questions about how the market is digesting the business’s fundamentals and future growth potential. Over the past year, Cencora’s share price has delivered a 38% total return, outpacing...

Why Cencora (COR) is a Top Growth Stock for the Long-Term

2025-09-26
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

1 Surging Stock with Exciting Potential and 2 We Find Risky

2025-09-26
The stocks in this article are all trading near their 52-week highs. This strength often reflects positive developments such as new product launches, favorable industry trends, or improved financial performance.

Kroll Settlement Administration Announces that The Lash Group, LLC Has Reached a Settlement Regarding a Data Security Incident

2025-09-23
CONSHOHOCKEN, Pa., September 23, 2025--The following statement is being issued by Kroll Settlement Administration regarding the Cencora Data Security Incident Settlement.

Top Analyst Reports for Apple, Eli Lilly & Chevron

2025-09-23
Apple grows Services with over 1B subscribers, while Eli Lilly and Chevron face mixed industry and market dynamics.

Why Cencora (COR) Stock Is Trading Up Today

2025-09-23
Shares of healthcare distributor Cencora (NYSE:COR) jumped 4.5% in the afternoon session after peer company McKesson raised its long-term earnings growth outlook, boosting investor sentiment across the pharmaceutical distribution sector.

Cencora Inc. stock outperforms competitors on strong trading day

2025-09-23
Cencora Inc. stock outperforms competitors on strong trading day

nuVizz to Showcase B2B Last-Mile Delivery Strategies at CSCMP EDGE 2025

2025-09-23
nuVizz joins industry leaders to share insights on achieving delivery resilience, agility and performance during an exclusive session on optimizing B2B last-mile logisticsATLANTA, Sept. 23, 2025 (GLOBE NEWSWIRE) -- nuVizz, a leading innovator in last-mile transportation management solutions (TMS), announced today it will be presenting alongside key partners Ford Motor Company, GEODIS, Cencora and Bart De Muynck LLC at the upcoming CSCMP EDGE 2025 Conference. The session, titled “How to Build Res

Cencora (COR) is a Top-Ranked Value Stock: Should You Buy?

2025-09-22
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Cencora Inc. stock underperforms Monday when compared to competitors

2025-09-15
Cencora Inc. stock underperforms Monday when compared to competitors